TABLE 2.
DHPS mutations in each patienta
| Patient no. | Sequence of DHPS mutantsb
|
No. of clones
|
Therapy for PCP | Treatment results | ||
|---|---|---|---|---|---|---|
| Nucleotide | Amino acid | Mutant | Wild type | |||
| 5 | ---165GCA CGG 171TCT--- | ---55Ala Arg 57Ser--- | 7 | 3 | Pentamidine | Success |
| 6 | ---165GCA CGG 171TCT--- | ---55Ala Arg 57Ser--- | 5 | 5 | Pentamidine | Success |
| 10 | ---165GCA CGG 171TCT--- | ---55Ala Arg 57Ser--- | 10 | 0 | Co-trimoxazole | Failure |
| 13 | ---165ACA CGG 171TCT--- | ---55Thr Arg 57Ser--- | 7 | 3 | Co-trimoxazole | Failure |
| 17 (first BAL fluid specimen) | ---165GCA CGG 171TCT--- | ---55Ala Arg 57Ser--- | 6 | 4 | Co-trimoxazole | Failure |
| 17 (second BAL fluid specimen) | ---165GCA CGG 171TCT--- | ---55Ala Arg 57Ser--- | 10 | 0 | ||
| 18 | ---165GCA CGG 171TCT--- | ---55Ala Arg 57Ser--- | 9 | 1 | Co-trimoxazole | Failure |
The mutations were confirmed by cloning and sequencing (10 clones) of each PCR product.
The nucleotide sequence of the wild type was 165ACA CGG 171CCT. The amino acid sequence of the wild type was 55Ala Arg 57Ser.